Mitochondrial dysfunction and oxidative damage to sarcomeric proteins

Current Hypertension Reports

Volumn 12, Issue 6, 2010, Pages 426-432

  Bayeva, Marina ^a   Ardehali, Hossein ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Contractile dysfunction; Diastolic dysfunction; Heart failure; Hypertension; Hypertrophy; Mitochondria; Myofibrils; ROS; Sarcomere

Indexed keywords

ALPHA ACTININ; CATALASE; GLUTATHIONE PEROXIDASE; MUSCLE PROTEIN; MYOSIN LIGHT CHAIN 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TROPOMYOSIN; TROPONIN T;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HUMAN; HYPERTENSION; MOLECULAR BIOLOGY; MUSCLE FIBRIL; NONHUMAN; OXIDATIVE STRESS; REVIEW; SARCOMERE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; HUMANS; HYPERTENSION; MICE; MITOCHONDRIA, HEART; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; SARCOMERES;

EID: 78649908978     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0149-8     Document Type: Review

References (53)

1. Cherry DK, Hing E, Woodwell DA, Rechtsteiner EA: National Ambulatory Medical Care Survey: 2006 summary. Natl Health Stat Report 2008(3):1-39.
2. MR Zile CF Baicu WH Gaasch 2004 Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle N Engl J Med 350 19 1953 1959 1:CAS:528:DC%2BD2cXjslehs7o%3D 10.1056/NEJMoa032566 15128895 (Pubitemid 38580198)
3. N Anilkumar A Sirker AM Shah 2009 Redox sensitive signaling pathways in cardiac remodeling, hypertrophy and failure Front Biosci 14 3168 3187 1:CAS:528:DC%2BD1MXltlWntbs%3D 10.2741/3443 19273265
4. TM Paravicini RM Touyz 2006 Redox signaling in hypertension Cardiovasc Res 71 2 247 258 1:CAS:528:DC%2BD28Xmt1ygs7o%3D 10.1016/j.cardiores.2006.05.001 16765337
5. H Nakagami M Takemoto JK Liao 2003 NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy J Mol Cell Cardiol 35 7 851 859 1:CAS:528:DC%2BD3sXks1artLo%3D 10.1016/S0022-2828(03)00145-7 12818576 (Pubitemid 36773597)
6. L Xiao DR Pimentel J Wang, et al. 2002 Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes Am J Physiol Cell Physiol 282 4 C926 C934 1:CAS:528: DC%2BD38XivVemu7w%3D 11880281
7. DR Pimentel JK Amin L Xiao, et al. 2001 Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes Circ Res 89 5 453 460 1:CAS:528:DC%2BD3MXmvFSrtL0%3D 10.1161/hh1701.096615 11532907
8. I Tsujimoto S Hikoso O Yamaguchi, et al. 2005 The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy Hypertension 45 5 921 926 1:CAS:528:DC%2BD2MXjtlylsr8%3D 10.1161/01.HYP.0000163461.71943.e9 15824197 (Pubitemid 40628938)
9. T Yamada K Nagata XW Cheng, et al. 2009 Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats Eur J Pharmacol 615 1-3 163 170 1:CAS:528:DC%2BD1MXnslyksL0%3D 10.1016/j.ejphar.2009.05.028 19501083
10. T Doenst G Pytel A Schrepper, et al. 2010 Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload Cardiovasc Res 86 3 461 470 1:CAS:528: DC%2BC3cXmtFKqtL4%3D 10.1093/cvr/cvp414 20035032 This study characterizes mitochondrial metabolic defects in a pressure-overload rat model of hypertrophy. Importantly, though impairment in fatty acid and glucose metabolism occurred early after transverse aortic constriction (TAC), mitochondrial respiratory capacity was preserved until 10 weeks after TAC, and its decrease correlated with impairment of ejection fraction
11. JC Lu W Cui HL Zhang, et al. 2009 Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats Clin Exp Pharmacol Physiol 36 11 1110 1119 1:CAS:528:DC%2BD1MXhsFKlt7jJ 10.1111/j.1440-1681.2009.05198.x 19413592
12. F Lacy MT Kailasam DT O'Connor, et al. 2000 Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity Hypertension 36 5 878 884 1:CAS:528:DC%2BD3cXptVSitb4%3D 11082160
13. J Pedro-Botet MI Covas S Martin J Rubies-Prat 2000 Decreased endogenous antioxidant enzymatic status in essential hypertension J Hum Hypertens 14 6 343 345 1:CAS:528:DC%2BD3cXksVCgsbw%3D 10.1038/sj.jhh.1001034 10878691
14. A Sirker M Zhang C Murdoch AM Shah 2007 Involvement of NADPH oxidases in cardiac remodelling and heart failure Am J Nephrol 27 6 649 660 1:CAS:528:DC%2BD2sXht1Wgt7fK 10.1159/000109148 17901689 (Pubitemid 350014953)
15. JK Bendall AC Cave C Heymes, et al. 2002 Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice Circulation 105 3 293 296 1:CAS:528:DC%2BD38XhsFSgtL4%3D 10.1161/hc0302.103712 11804982 (Pubitemid 34106175)
16. JA Byrne DJ Grieve JK Bendall, et al. 2003 Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy Circ Res 93 9 802 805 1:CAS:528:DC%2BD3sXotlejs70%3D 10.1161/01.RES.0000099504.30207.F5 14551238 (Pubitemid 37363053)
17. X Xu L Zhao X Hu, et al. 2010 Delayed treatment effects of xanthine oxidase inhibition on systolic overload-induced left ventricular hypertrophy and dysfunction Nucleosides Nucleotides Nucleic Acids 29 4-6 306 313 1:CAS:528:DC%2BC3cXnt1ymsbY%3D 10.1080/15257771003738683 20544512
18. T Ide H Tsutsui S Kinugawa, et al. 1999 Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium Circ Res 85 4 357 363 1:CAS:528:DyaK1MXltlehurg%3D 10455064
19. EM Redout MJ Wagner MJ Zuidwijk, et al. 2007 Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species Cardiovasc Res 75 4 770 781 1:CAS:528: DC%2BD2sXpt1Srsr8%3D 10.1016/j.cardiores.2007.05.012 17582388 (Pubitemid 47243719)
20. FC Chen O Ogut 2006 Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin Am J Physiol Cell Physiol 290 3 C719 C727 1:CAS:528: DC%2BD28Xjt1Sltbw%3D 10.1152/ajpcell.00419.2005 16251471
21. MB Reid 2008 Free radicals and muscle fatigue: Of ROS, canaries, and the IOC Free Radic Biol Med 44 2 169 179 1:CAS:528:DC%2BD1cXlvVygtQ%3D%3D 10.1016/j.freeradbiomed.2007.03.002 18191753
22. PA Figueiredo MP Mota HJ Appell JA Duarte 2008 The role of mitochondria in aging of skeletal muscle Biogerontology 9 2 67 84 1:CAS:528: DC%2BD1cXitlyrsLo%3D 10.1007/s10522-007-9121-7 18175203
23. D Graham NN Huynh CA Hamilton, et al. 2009 Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy Hypertension 54 2 322 328 1:CAS:528:DC%2BD1MXosFWiu78%3D 10.1161/HYPERTENSIONAHA.109.130351 19581509
24. T Daicho T Yagi Y Abe, et al. 2009 Possible involvement of mitochondrial energy-producing ability in the development of right ventricular failure in monocrotaline-induced pulmonary hypertensive rats J Pharmacol Sci 111 1 33 43 1:CAS:528:DC%2BD1MXht1ert7vL 10.1254/jphs.08322FP 19763046
25. EM Redout A van der Toorn MJ Zuidwijk, et al. 2010 Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure Am J Physiol Heart Circ Physiol 298 3 H1038 H1047 1:CAS:528:DC%2BC3cXjsFGns7k%3D 10.1152/ajpheart.00097.2009 20061549 Monocrotaline-induced RV heart failure in rats was successfully reversed with antioxidant EUK-134 administration. This superoxide dismutase and catalase mimetic targets both mitochondrial and cytosolic ROS and represents a potential therapeutic agent for treatment of RV dysfunction in pulmonary arterial hypertension.
26. m/m mice, which overexpress the mitochondria-targeted antioxidant enzyme catalase. This study supports the importance of mitochondrial ROS in the development of cardiac dysfunction and provides evidence for the therapeutic potential of mitochondria-targeted antioxidants.
27. T Loch O Vakhrusheva I Piotrowska, et al. 2009 Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice Cardiovasc Res 82 3 448 457 1:CAS:528:DC%2BD1MXmtFSjt7s%3D 19293248 Mice with inducible heterozygous deletion of SOD2, a mitochondrial antioxidant, develop cardiac hypertrophy, systolic dysfunction, and increased fibrosis. This study supports the hypothesis that increased mitochondrial ROS production is sufficient to induce cardiomyopathy
28. JJ Kohler I Cucoranu E Fields, et al. 2009 Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy Lab Invest 89 7 782 790 1:CAS:528:DC%2BD1MXnslKgsrc%3D 10.1038/labinvest.2009.39 19398959
29. AJ Marian 2008 Genetic determinants of cardiac hypertrophy Curr Opin Cardiol 23 3 199 205 10.1097/HCO.0b013e3282fc27d9 18382207 (Pubitemid 351489322)
30. CH Davies K Davia JG Bennett, et al. 1995 Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure Circulation 92 9 2540 2549 1:STN:280:DyaK28%2FmvFaktg%3D%3D 7586355
31. VG Sharov HN Sabbah H Shimoyama, et al. 1994 Abnormalities of contractile structures in viable myocytes of the failing heart Int J Cardiol 43 3 287 297 1:STN:280:DyaK2c3jslKnsA%3D%3D 10.1016/0167-5273(94)90209-7 8181886 (Pubitemid 24078755)
32. G Jagatheesan S Rajan DF Wieczorek 2010 Investigations into tropomyosin function using mouse models J Mol Cell Cardiol 48 5 893 898 1:CAS:528: DC%2BC3cXksFCrsLk%3D 10.1016/j.yjmcc.2009.10.003 19835881
33. AE Messer AM Jacques SB Marston 2007 Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure J Mol Cell Cardiol 42 1 247 259 1:CAS:528:DC%2BD2sXht1Cltw%3D%3D 10.1016/j.yjmcc.2006.08.017 17081561 (Pubitemid 44970468)
34. N Hamdani V Kooij S van Dijk, et al. 2008 Sarcomeric dysfunction in heart failure Cardiovasc Res 77 4 649 658 1:CAS:528:DC%2BD1cXjvVaju7c%3D 10.1093/cvr/cvm079 18055579 (Pubitemid 351301859)
35. E Barreiro SN Hussain 2010 Protein carbonylation in skeletal muscles: impact on function Antioxid Redox Signal 12 3 417 429 1:CAS:528: DC%2BC3cXitVahsb8%3D 10.1089/ars.2009.2808 19686036
36. M Fedorova N Kuleva R Hoffmann 2010 Identification, quantification, and functional aspects of skeletal muscle protein-carbonylation in vivo during acute oxidative stress J Proteome Res 9 5 2516 2526 1:CAS:528:DC%2BC3cXkvFaqt7Y%3D 10.1021/pr901182r 20377239 A series of recent papers from this group used an x-ray irradiation model of acute ROS production to study the dynamics and functional consequences of oxidative damage to sarcomeric proteins. Importantly, they found myofibrillar proteins to be preferentially carbonylated or degraded in states of enhanced ROS generation
37. JH Snook J Li BP Helmke WH Guilford 2008 Peroxynitrite inhibits myofibrillar protein function in an in vitro assay of motility Free Radic Biol Med 44 1 14 23 1:CAS:528:DC%2BD2sXhtlyrurnI 10.1016/j.freeradbiomed.2007.09.004 18045543 (Pubitemid 350138626)
38. VM Costa R Silva LC Tavares, et al. 2009 Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes Toxicology 260 1-3 84 96 1:CAS:528: DC%2BD1MXmtlOhsro%3D 10.1016/j.tox.2009.03.012 19464573
39. T Yamada T Mishima M Sakamoto, et al. 2007 Myofibrillar protein oxidation and contractile dysfunction in hyperthyroid rat diaphragm J Appl Physiol 102 5 1850 1855 1:CAS:528:DC%2BD2sXmt1aqsL4%3D 10.1152/japplphysiol.01177.2006 17303704 (Pubitemid 46701954)
40. M Canton I Neverova R Menabo, et al. 2004 Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts Am J Physiol Heart Circ Physiol 286 3 H870 H877 1:CAS:528:DC%2BD2cXitlShsrY%3D 10.1152/ajpheart.00714.2003 14766672
41. M de Paula Brotto SA van Leyen LS Brotto, et al. 2001 Hypoxia/fatigue-induced degradation of troponin I and troponin C: new insights into physiologic muscle fatigue Pflugers Arch 442 5 738 744 10.1007/ s004240100587 11512030 (Pubitemid 32783683)
42. M Fedorova N Kuleva R Hoffmann 2009 Reversible and irreversible modifications of skeletal muscle proteins in a rat model of acute oxidative stress Biochim Biophys Acta 1792 12 1185 1193 1:CAS:528:DC%2BD1MXhsVKntrnF 19786098
43. 2 resulted in oxidative modifications and impaired enzymatic activity of myofibrils, myosin, and actomyosin, which affected the contractile dynamics of the fibers. EPR spectroscopy analysis revealed a shift in confirmation of oxidized myosin heads towards the strong-binding structural state, providing the structural evidence for relaxation defects of the oxidized muscle. (Pubitemid 351264413)
44. E Prochniewicz D Spakowicz DD Thomas 2008 Changes in actin structural transitions associated with oxidative inhibition of muscle contraction Biochemistry 47 45 11811 11817 1:CAS:528:DC%2BD1cXht1Clur7N 10.1021/bi801080x 18855423
45. M Fedorova N Kuleva R Hoffmann 2010 Identification of cysteine, methionine and tryptophan residues of actin oxidized in vivo during oxidative stress J Proteome Res 9 3 1598 1609 1:CAS:528:DC%2BC3cXhtFKqurw%3D 10.1021/pr901099e 20063901
46. VS Rao LR La Bonte Y Xu, et al. 2007 Alterations to myofibrillar protein function in nonischemic regions of the heart early after myocardial infarction Am J Physiol Heart Circ Physiol 293 1 H654 H659 1:CAS:528:DC%2BD2sXovVyhsbo%3D 10.1152/ajpheart.01314.2006 17400716 (Pubitemid 47105126)
47. MY White SJ Cordwell HC McCarron, et al. 2003 Modifications of myosin-regulatory light chain correlate with function of stunned myocardium J Mol Cell Cardiol 35 7 833 840 1:CAS:528:DC%2BD3sXks1artLw%3D 10.1016/S0022-2828(03)00141-X 12818574 (Pubitemid 36773596)
48. M Canton A Skyschally R Menabo, et al. 2006 Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization Eur Heart J 27 7 875 881 1:CAS:528:DC%2BD28XjvFOntb4%3D 10.1093/eurheartj/ehi751 16434410
49. PP De Tombe T Wannenburg D Fan WC Little 1996 Right ventricular contractile protein function in rats with left ventricular myocardial infarction Am J Physiol 271 1 Pt 2 H73 H79 8760160
50. A van der Laarse 2002 Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure Cardiovasc Res 56 1 8 14 10.1016/S0008-6363(02)00534-5 12237161 (Pubitemid 35247797)
51. NA Narolska N Piroddi A Belus, et al. 2006 Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle Circ Res 99 1012 1020 1:CAS:528:DC%2BD28XhtFSlur%2FI 10.1161/01.RES.0000248753.30340.af 17023673 (Pubitemid 44657805)
52. MC Gomes-Marcondes MJ Tisdale 2002 Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress Cancer Lett 180 69 74 1:CAS:528:DC%2BD38XitFWmsro%3D 10.1016/S0304-3835(02)00006-X 11911972 (Pubitemid 34242966)
53. JM Predmore P Wang F Davis, et al. 2010 Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies Circulation 121 997 1004 1:CAS:528:DC%2BC3cXisFOlsLk%3D 10.1161/CIRCULATIONAHA.109.904557 20159828